Basit öğe kaydını göster

dc.contributor.authorZengin, Fatih
dc.contributor.authorDagistanli, Ahmet Serhan
dc.contributor.authorErelel, Mustafa
dc.date.accessioned2021-03-03T16:03:07Z
dc.date.available2021-03-03T16:03:07Z
dc.date.issued2020
dc.identifier.citationErelel M., Dagistanli A. S. , Zengin F., "ARGON PLASMA COAGULATION USE IN PALLIATIVE TREATMENT OF TYPICAL-ATYPICAL CARCINOID TUMORS", NOBEL MEDICUS, cilt.16, sa.1, ss.70-74, 2020
dc.identifier.othervv_1032021
dc.identifier.otherav_42298f08-ccc1-4a6c-ad9e-42f150cd9b39
dc.identifier.urihttp://hdl.handle.net/20.500.12627/48209
dc.description.abstractBronchial carcinoid tumors constitute 1-2% of all primary lung tumors. The main treatment for lung carcinoid tumors is surgery but bronchoscopic endobronchial therapy is also a palliative option for poor surgical candidates. This study will discuss the outcomes of bronchoscopic endobronchial treatment for two cases. Case 1 has a typical carcinoid tumor in right upper lobe and has multiple comorbidities. Case 2 is a patient with metastatic atypical carcinoid tumor who was operated before. We used argon plasma coagulation technique in treatment of both cases.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.subjectTemel Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.titleARGON PLASMA COAGULATION USE IN PALLIATIVE TREATMENT OF TYPICAL-ATYPICAL CARCINOID TUMORS
dc.typeMakale
dc.relation.journalNOBEL MEDICUS
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume16
dc.identifier.issue1
dc.identifier.startpage70
dc.identifier.endpage74
dc.contributor.firstauthorID2276193


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster